Hypothalamic Orexin Prevents Hepatic Insulin Resistance via Daily Bidirectional Regulation of Autonomic Nervous System in Mice
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Circadian rhythm is crucial for preventing hepatic insulin resistance, although the mechanism remains uncovered. Here we report that the wake-active hypothalamic orexin system plays a key role in this regulation. Wild-type mice showed that a daily rhythm in blood glucose levels peaked at the awake period; however, the glucose rhythm disappeared in orexin knockout mice despite normal feeding rhythm. Central administration of orexin A during nighttime awake period acutely elevated blood glucose levels but subsequently lowered daytime glucose levels in normal and diabetic db/db mice. The glucose-elevating and -lowering effects of orexin A were suppressed by adrenergic antagonists and hepatic parasympathectomy, respectively. Moreover, the expression levels of hepatic gluconeogenic genes, including Pepck, were increased and decreased by orexin A at nanomolar and femtomolar doses, respectively. These results indicate that orexin can bidirectionally regulate hepatic gluconeogenesis via control of autonomic balance, leading to generation of the daily blood glucose oscillation. Furthermore, during aging, orexin deficiency enhanced endoplasmic reticulum (ER) stress in the liver and caused impairment of hepatic insulin signaling and abnormal gluconeogenic activity in pyruvate tolerance test. Collectively, the daily glucose rhythm under control of orexin appears to be important for maintaining ER homeostasis, thereby preventing insulin resistance in the liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, central orexin A infusion inhibits high fat-induced hepatic inflammation and hyperphagia-induced systemic insulin resistance141,142.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [142]
Citations
Cites
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · cited 1×
“However, prolonged ER stress is detrimental and leads to the development of insulin resistance and type 2 diabetes (44,45).”
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,598 · cited 1×
“Moreover, ER stress can be mitigated by low-level preconditioning stimuli (48), and circadian clock–dependent rhythmic activation of the IRE1a signaling in the ER of liver is required for normal metabolic functions in mice (29).”
Hatori, M., Vollmers, C., Zarrinpar, A., DiTacchio, L., Bushong, E. A., Gill, S., Leblanc, M., Chaix, A., Joens, M., Fitzpatrick, J. A. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.019 · Cited by 1,986 · cited 1×
“Rather, it has been reported that nighttime-restricted feeding accompanied by nocturnal increase in carbohydrate utilization improved metabolic state in mice fed a high-fat diet (47).”
Differential expression of orexin receptors 1 and 2 in the rat brain
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., & Elmquist, J. K. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1190 · Cited by 1,659
Self-citationThe neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Sakurai, T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2092 · Cited by 1,276 · cited 4×
“Therefore, it is likely that the high dose of orexin A enhances the Pepck levels via the OX2R and sympathetic nerve pathways, whereas the low dose of orexin A suppresses them via the OX1R and parasympathetic pathways.”
InfluentialSelf-citationThe Role for Endoplasmic Reticulum Stress in Diabetes Mellitus
Eizirik, D. L., Cardozo, A. K., & Cnop, M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0015 · Cited by 1,173 · cited 2×
“ER is an organelle functionally linked to the circadian clock and insulin sensitivity (7,29).”
Date, Y., Ueta, Y., Yamashita, H., Yamaguchi, H., Matsukura, S., Kangawa, K., Sakurai, T., Yanagisawa, M., & Nakazato, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.748 · Cited by 1,050 · cited 1×
“Hypothalamic orexin neurons project to both sympathetic and parasympathetic preganglionic neurons in the central nervous system (33,34), and orexin activates both types of neurons (35,36).”
Self-citationHypothalamic Orexin Neurons Regulate Arousal According to Energy Balance in Mice
Yamanaka, A., Beuckmann, C. T., Willie, J. T., Hara, J., Tsujino, N., Mieda, M., Tominaga, M., Yagami, K.-I., Sugiyama, F., Goto, K., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00331-3 · Cited by 933 · cited 1×
“In diabetic mice such as db/db and ob/ob mice, orexin expression is suppressed due to hyperglycemia (15,38).”
Self-citationCircadian rhythms, sleep, and metabolism
Huang, W., Ramsey, K. M., Marcheva, B., & Bass, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46043 · Cited by 725 · cited 1×
“For instance, chronic disruption of circadian rhythm in humans, as seen in shift workers, increases the risk of obesity and type 2 diabetes (1,2), and circadian rhythms of glucose regulation are impaired in diabetic animals and patients with diabetes (3).”
Cited by
Central regulation of stress-evoked peripheral immune responses
Chan, K. L., Poller, W. C., Swirski, F. K., & Russo, S. J. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00729-2 · Cited by 207
Hypothalamic-autonomic control of energy homeostasis
Seoane-Collazo, P., Fernø, J., Gonzalez, F., Diéguez, C., Leis, R., Nogueiras, R., & López, M. (2015) · Endocrine · doi:10.1007/s12020-015-0658-y · Cited by 184
Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
Irukayama-Tomobe, Y., Ogawa, Y., Tominaga, H., Ishikawa, Y., Hosokawa, N., Ambai, S., Kawabe, Y., Uchida, S., Nakajima, R., Saitoh, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700499114 · Cited by 140
“Indeed, daily active-phase administrations of orexin-A prevented hepatic insulin resistance via bidirectional regulation of the autonomic nervous system (26), whereas daily resting-phase administrations of suvorexant for 2–4 wk improved glucose tolerance in obese mice (27).”
BackgroundSelf-citationCircadian blueprint of metabolic pathways in the brain
Greco, C. M., & Sassone–Corsi, P. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0096-y · Cited by 93
Anderson, G., Rodriguez, M., & Reiter, R. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215500 · Cited by 87
“The decrease in orexin levels over the course of aging is associated with heightened levels of endoplasmic reticulum (ER) stress [107], with ER stress associated with alterations in mitochondrial functioning, including during the course of insulin resistance [108].”
BackgroundCircadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon
Peng, F., Li, X., Xiao, F., Zhao, R., & Sun, Z. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.03.010 · Cited by 97
Fixing the broken clock in adrenal disorders: focus on glucocorticoids and chronotherapy
Minnetti, M., Hasenmajer, V., Pofi, R., Venneri, M. A., Alexandraki, K. I., & Isidori, A. M. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0066 · Cited by 70
A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer’s Disease
Peng, X., Fan, R., Xie, L., Shi, X., Dong, K., Zhang, S., Tao, J., Xu, W., Ma, D., Chen, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010504 · Cited by 70
Metabolic profile in patients with narcolepsy: a systematic review and meta-analysis
Mohammadi, S., Moosaie, F., Saghazadeh, A., Mahmoudi, M., & Rezaei, N. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.02.040 · Cited by 71
Orexins/Hypocretins: Key Regulators of Energy Homeostasis
Milbank, E., & López, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00830 · Cited by 63
“Indeed, the absence of orexin increases hepatic endoplasmic reticulum (ER) stress leading to decreased hepatic insulin sensitivity and altered gluconeogenic activity (90).”
BackgroundXiao, X., Yeghiazaryan, G., Heß, S., Klemm, P., Sieben, A., Kleinridders, A., Morgan, D. A., Wunderlich, F. T., Rahmouni, K., Kong, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25380-2 · Cited by 58
Obstructive Sleep Apnea, Circadian Clock Disruption, and Metabolic Consequences
Malicki, M., Karuga, F. F., Szmyd, B. M., Sochal, M., & Gabryelska, A. (2022) · Metabolites · doi:10.3390/metabo13010060 · Cited by 57
“This neuropeptide also regulates the expression of gluconeogenic genes, which suggests that orexin A can promote diurnal glucose rhythm via the regulation of gluconeogenesis [145].”
Nakamura, M., & Nagamine, T. (2017) · Europe PMC (PubMed Central) · Cited by 59
Roles for Orexin/Hypocretin in the Control of Energy Balance and Metabolism
Goforth, P. B., & Myers, M. G. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_51 · Cited by 51
Hindbrain Catecholamine Neurons Activate Orexin Neurons During Systemic Glucoprivation in Male Rats
Li, A., Wang, Q., Elsarelli, M. M., Brown, R. L., & Ritter, S. (2015) · Endocrinology · doi:10.1210/en.2015-1138 · Cited by 43
Tsuneki, H., Wada, T., & Sasaoka, T. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.010 · Cited by 45
Self-citationFood odor perception promotes systemic lipid utilization
Tsuneki, H., Sugiyama, M., Ito, T., Sato, K., Matsuda, H., Onishi, K., Yubune, K., Matsuoka, Y., Nagai, S., Yamagishi, T., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00673-y · Cited by 41
Self-citationTsuneki, H., Kon, K., Ito, H., Yamazaki, M., Takahara, S., Toyooka, N., Ishii, Y., Sasahara, M., Wada, T., Yanagisawa, M., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1404 · Cited by 36
Self-citationHypocretin/orexin modulates body weight and the metabolism of glucose and insulin
Adeghate, E. A., Lotfy, M. A., D’Souza, C. M., Alseiari, S., Alsaadi, A. A., & Qahtan, S. A. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3229 · Cited by 40
Liu, Y., Zhao, Y., & Guo, L. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.002 · Cited by 37
Sleep Control, GPCRs, and Glucose Metabolism
Tsuneki, H., Sasaoka, T., & Sakurai, T. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.06.011 · Cited by 38
“Once a sufficient amount of food is acquired for survival, orexin suppresses hepatic gluconeogenesis to avoid postprandial hyperglycemia [71].”
BackgroundSelf-citationCentral Circadian Clock Regulates Energy Metabolism
Ding, G., Gong, Y., Eckel-Mahan, K. L., & Sun, Z. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-1286-1_5 · Cited by 33
“Although ICV administration of orexin during the day increased blood glucose levels in mice, orexin administration at night decreased blood glucose levels associated with reduced gluconeogenesis gene expression, an effect that can be blocked by hepatic parasympathectomy (Tsuneki et al., 2015).”
BackgroundSleep restriction acutely impairs glucose tolerance in rats
Jha, P. K., Foppen, E., Kalsbeek, A., & Challet, É. (2016) · Physiological Reports · doi:10.14814/phy2.12839 · Cited by 33
“Finally, orexin has bidirectional effects on hepatic gluconeogenesis via the autonomic nervous system (Tsuneki et al. 2015).”
BackgroundChen, P., Chen, C.-H., Chang, C., Kao, C.-F., Lu, M., Lin, S., Huang, M., Hwang, L.-L., & Mondelli, V. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy075 · Cited by 32
“, 2018), and reduce peripheral insulin resistance (Tsuneki et al., 2015).”
BackgroundRani, M., Kumar, R., & Krishan, P. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.02.002 · Cited by 31
Orexins (hypocretins) and energy balance: More than feeding
Fernø, J., Señarís, R. M., Diéguez, C., Tena‐Sempere, M., & López, M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.07.022 · Cited by 28
Wan, X., Liu, Y., Zhao, Y., Sun, X., Fan, D., & Guo, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184213 · Cited by 27
Katashima, C. K., Micheletti, T. O., Braga, R. R., Gaspar, R. S., Goeminne, L. J. E., Moura‐Assis, A., Crisol, B., Brícola, R. S., Silva, V. R. R., Ramos, C. D. O., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm7355 · Cited by 30
Body Weight and Metabolic Rate Changes in Narcolepsy: Current Knowledge and Future Directions
Dhafar, H. O., & BaHammam, A. S. (2022) · Metabolites · doi:10.3390/metabo12111120 · Cited by 29
“Orexin reduces insulin resistance and endoplasmic reticulum stress in the mouse liver [85].”
BackgroundNutrition in the spotlight: metabolic effects of environmental light
Versteeg, R. I., Stenvers, D. J., Kalsbeek, A., Bisschop, P. H. L. T., Serlie, M. J. M., & la Fleur, S. E. (2016) · Proceedings of The Nutrition Society · doi:10.1017/s0029665116000707 · Cited by 30
“Orexin affects both glucose production and insulin sensitivity((53,54)) and with its circadian rhythmicity could be an important mechanism for the SCN to influence glucose metabolism.”
Hypothalamic orexin prevents non-alcoholic steatohepatitis and hepatocellular carcinoma in obesity
Tsuneki, H., Maeda, T., Takata, S., Sugiyama, M., Otsuka, K., Ishizuka, H., Onogi, Y., Tokai, E., Koshida, C., Kon, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111497 · Cited by 21
Self-citationRemote control of glucose-sensing neurons to analyze glucose metabolism
Alvarsson, A., & Stanley, S. A. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00469.2017 · Cited by 22
Wang, L., He, T., Wan, B., Wang, X., & Zhang, L. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1614014 · Cited by 19
“In a prediabetes mouse model, the administration of orexin A has been shown to prevent hepatic insulin resistance [13].”
BackgroundTsuneki, H., Nagata, T., Fujita, M., Kon, K., Wu, N., Takatsuki, M., Yamaguchi, K., Wada, T., Nishijo, H., Yanagisawa, M., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1488 · Cited by 21
Self-citationZhang, Z., Wang, S., & Gao, L. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1537231 · Cited by 24
Diepenbroek, C., Rijnsburger, M., van Irsen, A. A. S., Eggels, L., Kisner, A., Foppen, E., Unmehopa, U. A., Berland, C., Dólleman, S., Hardonk, M. H., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155696 · Cited by 18
Suprachiasmatic Nucleus Neuropeptides and Their Control of Endogenous Glucose Production
Foppen, E., Tan, A. A. T., Ackermans, M. T., Fliers, E., & Kalsbeek, A. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12365 · Cited by 20
Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options
Mohammadi, S., Dolatshahi, M., Zare-Shahabadi, A., & Rahmani, F. (2019) · Brain Research · doi:10.1016/j.brainres.2019.04.013 · Cited by 20
Orexinergic pathway as a potential therapeutic candidate for the modulation of glucose homeostasis
Hakizimana, J. C., Izabayo, P., Izukwizabigenza, Z., & Alagbonsi, A. I. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1659753 · Cited by 18
Zarifkar, M., Noshad, S., Shahriari, M., Afarideh, M., Khajeh, E., Karimi, Z., Ghajar, A., & Esteghamati, A. (2017) · The Review of Diabetic Studies · doi:10.1900/rds.2017.14.301 · Cited by 20
Chen, P., Chang, C., Chen, C.-H., Fang, S., Mondelli, V., Chiu, C., Lu, M., Hwang, L.-L., & Huang, M. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.03.008 · Cited by 16
Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1‐driven gluconeogenesis
Liu, N., Yang, X., Guo, J., Zhang, L., Huang, S., Chen, J., Huang, J., Chen, Y., Cui, T., Zheng, Y., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256390 · Cited by 17
Alam, T., Rizwan, S., Farooqui, Z., Abidi, S., Parwez, I., & Khan, F. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13493-6 · Cited by 14
Neuroendocrine and Behavioral Consequences of Hyperglycemia in Cancer
Vasquez, J. H., & Borniger, J. C. (2020) · Endocrinology · doi:10.1210/endocr/bqaa047 · Cited by 14
Mehdi, M. E., Takhlidjt, S., Devère, M., Arabo, A., Solliec, M.-A. L., Maucotel, J., Bénani, A., Nédélec, E., Duparc, C., Lefranc, B., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05706-5 · Cited by 16
“Indeed, central administration of orexin A during the night-time awake period first elevates blood glucose levels and subsequently lowers daytime glycaemia in normal and diabetic db/db mice by bidirectional regulation of HGP relayed by the autonomic nervous system [29, 30].”
BackgroundPignatelli, J., de Sevilla, M. E. F., Sperber, J. E., Horrillo, D., Medina‐Gómez, G., & Torres‐Alemán, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094679 · Cited by 13
“Similar results were reported in male orexin knockout (KO) mice [44].”
MethodResultSaderi, N., Báez‐Ruíz, A., Azuara-Alvarez, L. E., Escobar, C., & Salgado‐Delgado, R. (2019) · Journal of Biological Rhythms · doi:10.1177/0748730419828534 · Cited by 12
Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study
Nakamura, M., & Nagamine, T. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000354 · Cited by 12
“Orexin neurons, which are known to regulate sleep/wake stability, feeding behavior, autonomic nerve activity and energy metabolism, can bidirectionally regulate hepatic gluconeogenesis via control of autonomic balance, leading to the generation of the daily blood glucose oscillation and preventing insulin resistance (…”
BackgroundNakamura, M., & Nagamine, T. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12608 · Cited by 9
“Hypothalamic orexin neurons, which are known to regulate sleep/wake stability, feeding behavior, autonomic nerve activity, and energy metabolism, can bidirectionally regulate hepatic gluconeogenesis via control of autonomic balance, leading to generation of the daily blood glucose oscillation and preventing insulin re…”
BackgroundMetabolic disturbances in children with narcolepsy: a retrospective study
Zhang, M., Thieux, M., Arvis, L., Lin, J., Guyon, A., Plancoulaine, S., Villanueva, C., & Franco, P. (2023) · SLEEP · doi:10.1093/sleep/zsad076 · Cited by 10
Chronotherapeutic effect of orexin antagonists on glucose metabolism in diabetic mice
Kon, K., Tsuneki, H., Ito, H., Takemura, Y., Sato, K., Yamazaki, M., Ishii, Y., Sasahara, M., Rudich, A., Maeda, T., et al. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0708 · Cited by 9
Self-citationSantiago, J. C. P., Otto, M., Kern, W., Baier, P. C., & Hallschmid, M. (2018) · Peptides · doi:10.1016/j.peptides.2018.02.005 · Cited by 8
Tsuneki, H., Sugiyama, M., Sato, K., Ito, H., Nagai, S., Kon, K., Wada, T., Kobayashi, N., Okada, T., Toyooka, N., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176190 · Cited by 6
Self-citationHypothalamic circuits and aging: keeping the circadian clock updated
Vázquez-Lizárraga, R., Mendoza-Viveros, L., Cid‐Castro, C., Ruiz-Montoya, S., Carreño‐Vázquez, E., & Orozco-Solís, R. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389624 · Cited by 8
“Importantly, the loss of orexin rhythms during aging disrupts the daily recovery from stress, leading to a chronic ER stress state and insulin resistance (Tsuneki et al., 2015).”
BackgroundYang, L., Zhi, S., Hu, J., Zhang, W., Zhang, Y., Qin, C., Yang, G., Yan, X., & Nie, G. (2020) · Aquaculture Reports · doi:10.1016/j.aqrep.2020.100528 · Cited by 6
Involvement of orexin in lipid accumulation in the liver
Mochizuki, A., Nakayama, K., Nakamura, S., Dantsuji, M., Kamijo, R., Shioda, S., Sakurai, T., Ozeki, M., & Inoue, T. (2018) · Journal of Oral Biosciences · doi:10.1016/j.job.2018.07.001 · Cited by 5
Self-citationBiological Susceptibility of Patients with Schizophrenia to Metabolic Syndrome: A Review
Ma, J., Huang, Z., Chen, J., & Wang, G. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap39896 · Cited by 3
“It increases lipolysis and insulin sensitivity and exerts protective effects related to metabolism [79,80].”
Alizadeh, A. A., Farhad, R., Mohebbi, H., & Zakerkish, M. (2015) · Iranian journal of diabetes and obesity · Cited by 4
Tsuneki, H., Honda, K., Sekine, Y., Yahata, K., Yasue, M., Fujishima, M., Takeda, R., Wada, T., & Sasaoka, T. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176306 · Cited by 3
Self-citationRole of circadian rhythms in metabolic syndrome
Bhatnagar, A., Puppala, A., Rankawat, S., Ray, S., & Ray, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00006-2 · Cited by 3
Regulatory cycles of orexin and glucagon-Like peptide-1 in postviral syndromes
Ruhrländer, J., Schieffer, E., & Schieffer, B. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag009 · Cited by 2
Tsuneki, H., Maeda, T., Takatsuki, M., Sekine, T., Masui, S., Onishi, K., Takeda, R., Sugiyama, M., Sakurai, T., Yanagisawa, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320157 · Cited by 3
“A hypothalamic neuropeptide orexin has been reported to exert biphasic changes in blood glucose levels, similar to bromocriptine [39].”
Self-citationPharmacology of Orexin/Hypocretin Receptors
Kukkonen, J. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813751-2.00002-4 · Cited by 2
Sugiyama, M., Tsuneki, H., Onishi, K., Yubune, K., Yamagishi, T., Sano, S., Tanaka, Y., Takasaki, I., Sakurai, T., Yanagisawa, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333176 · Cited by 1
“Orexin-deficient mice ( Orexin -/- , the N11 generation backcrossed to C57BL/6J mice) were prepared as previously described [17].”
InfluentialSelf-citationMcIntyre, R. S., & Wong, S. (2026) · CNS Spectrums · doi:10.1017/s1092852926101126 · Cited by 1
“23 Neuronal projections from the SCN to the orexin-containing neurons increase orexin secretion and exert effects on peripheral glucose homeostasis.”
InfluentialOrexin Regulates Glucose Homeodynamics with Daily Rhythm
Tsuneki, H., Wada, T., & Sasaoka, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23078-8_21 · Cited by 1
Self-citationFixing the broken clock in adrenal disorders: Focus on glucocorticoids and chronotherapy
Minnetti, M., Hasenmajer, V., Pofi, R., Venneri, M. A., Alexandraki, K. I., & Isidori, A. M. (2020) · Yearbook of pediatric endocrinology · doi:10.1530/ey.17.8.19
Jia, X. (2025) · Medicine · doi:10.1097/md.0000000000044040
“[13] The strong association between PBP4 levels and insulin resistance observed in our study is in line with recent findings that have identified PBP4 as a potential biomarker for evaluating insulin resistance and β -cell dysfunction.”
Sleep deprivation and its impact on circadian rhythms and glucose metabolism
Jha, P. K. (2016) · theses.fr (ABES) · doi:10.70675/090a1809z3e96z4876zbbcez4a3609e56272
“gluconeogenesis via the autonomic nervous system (Tsuneki et al., 2015).”
Suvorexant protects from ocular complications of diabetes in db/db mice
Sodhi, R. K., Mahajan, N. S., Abhyankar, S. D., & Bhatwadekar, A. D. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005476
生活習慣病予防におけるアミノ酸の中枢性肝糖産生抑制作用の有用性の解明
井上, 啓., & Inoue, H. (2017) · Institutional Repositories DataBase (IRDB) · doi:10.24517/00055333
Self-citationShukla, A., Geer, J. H., Nokes, B. T., & Wojeck, B. S. (2026) · Function · doi:10.1152/function.90001.2026
“In the liver, orexin suppresses gluconeogenesis via peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 a ) downregulation and maintains endoplasmic reticulum (ER) homeostasis through daily bidirectional regulation of the autonomic nervous system (6, 47).”
Metadata
- Authors
- Tsuneki, H., Tokai, E., Nakamura, Y., Takahashi, K., Fujita, M., Asaoka, T., Kon, K., Anzawa, Y., Wada, T., Takasaki, I., Kimura, K., Inoue, H., Yanagisawa, M., Sakurai, T., & Sasaoka, T.
- Affiliations
- University of Toyama (JP)
- Kanazawa University (JP)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Tsuneki, Hiroshi
- Sasaoka, Toshiyasu
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-09-22
- Volume
- 64
- Issue
- 2
- Pages
- 459-470
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2118822805
- Cited by
- 73
- References
- 48
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 1 · 2023: 7 · 2022: 11 · 2021: 5 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 6 · 2016: 7 · 2015: 8
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Nipro
- Japan Society for the Promotion of Science (24591317, 24390056)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- orexin, hepatic insulin resistance, circadian rhythm, autonomic nervous system, hepatic gluconeogenesis, endoplasmic reticulum stress, aging, db/db mice, hepatic insulin signaling, parasympathetic nervous system, adrenergic system, glucose tolerance
- MeSH terms
- Orexins, Animals, Autonomic Nervous System, Blood Glucose, Circadian Rhythm, Epinephrine, Hypothalamus, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Neuropeptides, Neurotransmitter Agents, Genes, Transgenic, Suicide, Intracellular Signaling Peptides and Proteins, Mice, Receptors, Leptin, Orexin Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.